All Updates

All Updates

icon
Filter
Partnerships
SOPHiA GENETICS partners with Microsoft and NVIDIA to develop whole-genome analytical solution
Precision Medicine
May 29, 2024
This week:
Geographic expansion
Partnerships
Lemonade partners with Homesite to expand home insurance services
InsurTech: Personal Lines
Jun 14, 2024
Funding
BayaniPay raises USD 3 million in seed funding to expand payment solutions
Neobanks
Jun 14, 2024
Partnerships
Carbonfuture and Swiss Re partner for long-term carbon removal through biochar
Carbon Management Software
Jun 13, 2024
Funding
Sidekick raises GBP 8.5 million in seed and debt funding to support expansion
Retail Trading Infrastructure
Jun 13, 2024
Partnerships
Climatiq and Epicor partner to reduce CO2 emissions in supply chains
Carbon Management Software
Jun 13, 2024
Product updates
EHang's pilotless eVTOL aircraft concludes first flight launch in Saudi Arabia
Passenger eVTOL Aircraft
Jun 13, 2024
Partnerships
Skyports partners with Unified Aviation to accelerate global network release
Passenger eVTOL Aircraft
Jun 13, 2024
Industry news
Partnerships
USSF chooses Blue Origin, SpaceX, and ULA for ~USD 5.6 billion Pentagon launch contracts
Space Travel and Exploration Tech
Jun 13, 2024
Funding
AnyCreek raises USD 1.8 million in seed funding to enhance platform and expand into new markets
Travel Tech
Jun 13, 2024
Funding
Zeta Labs raises USD 2.9 million in pre-seed funding to develop autonomous AI agent
Generative AI Applications
Jun 13, 2024
Precision Medicine

Precision Medicine

May 29, 2024

SOPHiA GENETICS partners with Microsoft and NVIDIA to develop whole-genome analytical solution

Partnerships

  • SOPHiA GENETICS has partnered with Microsoft and NVIDIA to develop a whole-genome sequencing (WGS) analytical solution to offer streamlined and scalable insights to healthcare providers.

  • The solution aims to deliver fully analyzed genomic insights within the same day of sequencing. The solution leverages Microsoft Azure and NVIDIA's technology to improve the speed and accuracy of insights, supporting diagnosis and treatment decisions for cancer and rare inherited genetic disorders. The solution, which is slated to be available by the end of the year, aims to enhance clinical research, drug discovery, and care delivery.

Contact us

Gain access to all industry hubs, market maps, research tools, and more
Get a demo
arrow
menuarrow

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.